Literature DB >> 9733943

Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells.

T Mizuno1, C Haass, M Michikawa, K Yanagisawa.   

Abstract

To investigate the implications of altered sorting of the beta-amyloid precursor protein (betaAPP) in the abnormal generation of amyloid beta-protein (Abeta), we characterized Abeta secreted from Madin-Darby canine kidney (MDCK) cells which had been stably transfected with a cDNA encoding the human beta-amyloid precursor protein (betaAPP695) with a 42 amino acid residue truncation at the carboxyl terminus (DeltaC). In DeltaC MDCK cells, the intracellular sorting of betaAPP is substantially altered to the apical surface. We detected an accumulation of a unique Abeta species in the apical compartment of DeltaC MDCK cell cultures. This unique Abeta was immunoprecipitated with 4G8 (a monoclonal antibody specific for Abeta17-24) and detected as a smear on Western blots, but was not immunoprecipitated with BAN50 (a monoclonal antibody raised against Abeta1-16). Interestingly, however, this Abeta species was readily immunoprecipitated with BAN50 upon treatment with formic acid. Furthermore, incubation of the DeltaC MDCK cells with compactin, an inhibitor of de novo cholesterol synthesis, or with filipin, a cholesterol-binding drug, resulted in marked changes in the characteristics of this Abeta species as follows: first, the Abeta was not observed as a smear on Western blots and second, the Abeta was immunoprecipitated with BAN50. The present results strongly suggest that an Abeta with unique molecular characteristics is generated from the missorted betaAPP in vivo in a cholesterol-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733943     DOI: 10.1016/s0005-2736(98)00097-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides.

Authors:  G K Gouras; H Xu; R S Gross; J P Greenfield; B Hai; R Wang; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway.

Authors:  J L Galbete; T R Martin; E Peressini; P Modena; R Bianchi; G Forloni
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 4.  Alpha-synuclein: its biological function and role in neurodegenerative diseases.

Authors:  Batia Kaplan; Vladimir Ratner; Elisha Haas
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

Review 5.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

6.  Statin therapy for Alzheimer's disease: will it work?

Authors:  Suzana S Petanceska; Steven DeRosa; Vicki Olm; Nichole Diaz; Ali Sharma; Tara Thomas-Bryant; Karen Duff; Miguel Pappolla; Lorenzo M Refolo
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

7.  Inhibitory effects of Bombusae concretio Salicea on neuronal secretion of Alzheimer's beta-amyloid peptides, a neurodegenerative peptide.

Authors:  Ji-Cheon Jeong; Sung-Koo Kang; Cheol-Ho Yoon; Young-Joon Seo; Cher-Won Hwang; Jeong-Heon Ko; Young-Choon Lee; Young-Chae Chang; Cheorl-Ho Kim
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.